Page last updated: 2024-10-26

disopyramide and Seizures

disopyramide has been researched along with Seizures in 6 studies

Disopyramide: A class I anti-arrhythmic agent (one that interferes directly with the depolarization of the cardiac membrane and thus serves as a membrane-stabilizing agent) with a depressant action on the heart similar to that of guanidine. It also possesses some anticholinergic and local anesthetic properties.
disopyramide : A monocarboxylic acid amide that is butanamide substituted by a diisopropylamino group at position 4, a phenyl group at position 2 and a pyridin-2-yl group at position 2. It is used as a anti-arrhythmia drug.

Seizures: Clinical or subclinical disturbances of cortical function due to a sudden, abnormal, excessive, and disorganized discharge of brain cells. Clinical manifestations include abnormal motor, sensory and psychic phenomena. Recurrent seizures are usually referred to as EPILEPSY or seizure disorder.

Research Excerpts

ExcerptRelevanceReference
"SUN 1165 had no effect on clonic convulsions induced by pentetrazol and pictrotoxin in mice, while both mexiletine and lidocaine prolonged the duration of clonic convulsions."1.27General pharmacological studies on N-(2,6-dimethylphenyl)-8-pyrrolizidineacetamide hydrochloride hemihydrate. 1st communication: effect on the central nervous system. ( Hashimoto, Y; Hatta, M; Hattori, Y; Hirotsu, I; Ishihara, T; Kihara, T; Kitakaze, Y; Miyata, T; Nakamura, S; Takahama, K, 1988)

Research

Studies (6)

TimeframeStudies, this research(%)All Research%
pre-19904 (66.67)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (16.67)24.3611
2020's1 (16.67)2.80

Authors

AuthorsStudies
Dawidowski, M2
Król, M2
Szulczyk, B2
Chodkowski, A1
Podsadni, P2
Konopelski, P1
Ufnal, M2
Szuberski, P1
Wróbel, MZ1
Zhang, Y1
El Harchi, A1
Hancox, JC1
Jarkovska, D1
Mistrova, E1
Sviglerova, J1
Štengl, M1
Popowicz, GM1
Turło, J2
Drapała, A1
Malavé, A1
Holsapple, MP1
Yim, GK1
O'Keefe, B1
Holt, DW2
Hayler, AM2
Medd, RK2
O'Keeffe, B1
Hirotsu, I1
Kihara, T1
Nakamura, S1
Hattori, Y1
Hatta, M1
Kitakaze, Y1
Takahama, K1
Hashimoto, Y1
Miyata, T1
Ishihara, T1

Other Studies

6 other studies available for disopyramide and Seizures

ArticleYear
Structure-activity relationship and cardiac safety of 2-aryl-2-(pyridin-2-yl)acetamides as a new class of broad-spectrum anticonvulsants derived from Disopyramide.
    Bioorganic chemistry, 2020, Volume: 98

    Topics: Acetamides; Animals; Anticonvulsants; Disopyramide; Dose-Response Relationship, Drug; Electroshock;

2020
Characterization of Disopyramide derivative ADD424042 as a non-cardiotoxic neuronal sodium channel blocker with broad-spectrum anticonvulsant activity in rodent seizure models.
    European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences, 2016, Jan-01, Volume: 81

    Topics: Animals; Anti-Arrhythmia Agents; Anticonvulsants; Disease Models, Animal; Disopyramide; Electrocardi

2016
Local anesthetic activity and disopyramide toxicity.
    Archives internationales de pharmacodynamie et de therapie, 1983, Volume: 263, Issue:2

    Topics: Action Potentials; Anesthetics, Local; Animals; Disopyramide; In Vitro Techniques; Lethal Dose 50; M

1983
Convulsion after disopyramide.
    Lancet (London, England), 1978, Dec-02, Volume: 2, Issue:8101

    Topics: Disopyramide; Drug Evaluation; Humans; Pyridines; Seizures

1978
Treatment of disopyramide overdosage.
    The Medical journal of Australia, 1979, Mar-24, Volume: 1, Issue:6

    Topics: Antidotes; Bradycardia; Disopyramide; Humans; Isoproterenol; Pyridines; Seizures

1979
General pharmacological studies on N-(2,6-dimethylphenyl)-8-pyrrolizidineacetamide hydrochloride hemihydrate. 1st communication: effect on the central nervous system.
    Arzneimittel-Forschung, 1988, Volume: 38, Issue:10

    Topics: Administration, Oral; Animals; Anti-Arrhythmia Agents; Body Temperature; Catalepsy; Cats; Central Ne

1988